Use of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/335 (2006.01) A61P 27/02 (2006.01) A61P 43/00 (2006.01) C07D 313/12 (2006.01)

Patent

CA 2306393

Ophthalmic formulations containing as an active ingredient 11-(3- dimethylaminopropylidene) -6,11-dihydrodibenz[b,e]oxepin-2-acetic acid or a pharmaceutically acceptable salt thereof are useful for inhibiting cytokine release (e.g., IL-6 and IL-8) from human ocular cells. Such formulations can be used to treat or prevent ocular neovascularization and non-allergic inflammatory disorders such as dry-eye, keratitis, blepharitis, uveitis and inflammation related to infection.

Des formulations ophtalmiques contenant en tant que principe actif de l'acide 11-(3-diméthylaminopropylidène) -6,11-dihydrodibenz POUND b,e]oxépin-2-acétique ou un sel pharmaceutique acceptable de celui-ci sont utiles pour empêcher la libération de cytokine (par exemple, IL-6 et IL-8) par les cellules oculaires humaines. Ces formulations peuvent être utilisées pour traiter ou prévenir la néoformation de vaisseaux sanguins oculaires et les troubles inflammatoires non allergiques tels que l'oeil sec, la kératite, la blépharite, l'uvéite et l'inflammation associée à l'infection.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1949072

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.